Literature DB >> 20682380

Triamcinolone crystal size.

Mark E Kleinman, Scott J Westhouse, Jayakrishna Ambati, P Andrew Pearson, Lawrence S Halperin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20682380      PMCID： PMC3066155          DOI： 10.1016/j.ophtha.2010.01.052

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  5 in total

1.  Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use.

Authors:  J García-Arumí; A Boixadera; J Giralt; V Martinez-Castillo; F Gomez-Ulla; B Corcostegui; E García-Arumí
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

2.  Influence of different purification techniques on triamcinolone yield and particle size spectrum.

Authors:  Peter Szurman; Radoslaw Kaczmarek; Gesine B Jaissle; Salvatore Grisanti; Matthias Lüke; Martin S Spitzer; Peter-Edgar Heide; Karl U Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-09-28       Impact factor: 3.117

3.  Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administration.

Authors:  Hyuncheol Kim; Karl G Csaky; Luisa Gravlin; Peng Yuan; Robert J Lutz; Peter M Bungay; Ginger Tansey; Francisco DE Monasterio; Gopal K Potti; George Grimes; Michael R Robinson
Journal:  Retina       Date:  2006 May-Jun       Impact factor: 4.256

4.  Triamcinolone acetonide preparations: impact of crystal size on in vitro behavior.

Authors:  Andrew A Moshfeghi; Alex K Nugent; Hiroyuki Nomoto; Steven R Sanislo; John W Kitchens; Darius M Moshfeghi
Journal:  Retina       Date:  2009-05       Impact factor: 4.256

5.  Increased incidence of sterile endophthalmitis following intravitreal preserved triamcinolone acetonide.

Authors:  J Jonisch; J C Lai; V A Deramo; A J Flug; D M Fastenberg
Journal:  Br J Ophthalmol       Date:  2008-08       Impact factor: 4.638
  5 in total
  2 in total

1.  Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells.

Authors:  Siva P Kambhampati; Manoj K Mishra; Panagiotis Mastorakos; Yumin Oh; Gerard A Lutty; Rangaramanujam M Kannan
Journal:  Eur J Pharm Biopharm       Date:  2015-02-19       Impact factor: 5.571

2.  Vitreous opacities after intravitreal triamcinolone injection- a case report.

Authors:  Dhanashree Ratra; Vineet Ratra; Haard Shah
Journal:  BMC Ophthalmol       Date:  2018-06-20       Impact factor: 2.209
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.